SciELO - Scientific Electronic Library Online

 
vol.18Correlation between nutritional assessment and oxidative stress in candidates for liver transplantINSAF-HAS: a tool to select patients with hypertension for pharmaceutical care author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Einstein (São Paulo)

Print version ISSN 1679-4508On-line version ISSN 2317-6385

Einstein (São Paulo) vol.18  São Paulo  2020  Epub Dec 13, 2019

https://doi.org/10.31744/einstein_journal/2020ao4723 

ORIGINAL ARTICLE

Scientometrics on interventions used for adherence of hypertension and diabetes therapies

Julio de Souza Sá1 
http://orcid.org/0000-0002-0852-017X

Lucas França Garcia1 
http://orcid.org/0000-0002-5815-6150

Marcelo Picinin Bernuci1 
http://orcid.org/0000-0003-2201-5978

Mirian Ueda Yamaguchi1 
http://orcid.org/0000-0001-5065-481X

1Centro Universitário de Maringá, Maringá, PR, Brazil.


ABSTRACT

Objective

To identify interventions aimed to improve adherence to medical and non-medical antihypertensive and antidiabetic therapy.

Methods

Scientometric study conducted in February and March 2018, based on data collected on PubMed ® and SciELO databases, using the following search terms: “interventions to improve adherence to diabetes therapy”, “interventions to improve adherence to hypertension therapy” and “interventions to improve adherence to therapy for hypertension and diabetes”.

Results

A total of 95 articles were selected. Scientific production increased as of 2009, with a higher number of studies published between 2015 and 2017. Most interventions described in literature were aimed at diabetic patients (46.31%). Face-to-face interventions were more common (46.31%), followed by telephone-based (31.58%) and digital (26.31%) interventions. North America stood out as the continent with the highest number of publications (68.42%), followed by Europe (14.74%). Most studies (63.16%) were based on a single type of intervention.

Conclusion

Traditional intervention methods were more widely used to promote adherence to antihypertensive and antidiabetic therapy; digital technology emerged as a trend in interventions aimed to improve hypertension and diabetes-related health behaviors.

Key words: Health promotion; Drug therapy; Hypertension; Diabetes mellitus; Community health nursing; Ambulatory care; Patient care team; Biomedical technology; Bibliometrics

RESUMO

Objetivo

Identificar as intervenções utilizadas para melhorar a adesão de terapias medicamentosas e não medicamentosas de pacientes hipertensos e diabéticos.

Métodos

Estudo cienciométrico realizado nos meses de fevereiro e março de 2018, utilizando os termos “intervenções para melhorar a adesão à terapia do diabetes”, “intervenções para melhorar a adesão à terapia de hipertensão” e “intervenções para melhorar a adesão à terapia da hipertensão e diabetes”, nas bases de dados PubMed®e SciELO.

Resultados

Foram selecionados 95 artigos. A partir do ano 2009, observou-se crescimento da produção científica com maior volume entre os anos 2015 e 2017. O maior número de intervenções encontradas na literatura foi para pacientes com diabetes (46,31%). A intervenções mais utilizadas foram a face a face (46,31%), por chamada telefônica (31,58%) e a digital (26,31%). A América do Norte destacou-se no número de pesquisas, com 68,42% das publicações, seguida pela Europa, com 14,74%. Dentre os estudos, a maioria (63,16%) utilizou apenas um tipo de intervenção.

Conclusão

Métodos de intervenção tradicionais foram mais empregados para promover a adesão às terapias anti-hipertensão e antidiabetes, embora o uso de tecnologias digitais desponte como tendência para melhorar esses comportamentos de saúde.

Palavras-Chave: Promoção da saúde; Tratamento farmacológico; Hipertensão; Diabetes mellitus; Enfermagem em saúde comunitária; Assistência ambulatorial; Equipe interdisciplinar de saúde; Tecnologia biomédica; Bibliometria

INTRODUCTION

Hypertension and diabetes mellitus are among the major causes of death due to non-communicable chronic diseases (NCDs) worldwide, with a global prevalence of 22% in hypertensive individuals, and approximately 9.4 million related deaths per year.1 Global prevalence in diabetic individuals is roughly 9%, with more than 1.5 million related deaths annually.2 In these settings, adherence to medical and non-medical treatment of hypertension and diabetes is a major challenge in health promotion.3

The rate of hypertension- and diabetes-related complications is constantly on the rise in middle- and low-income countries. This is partly due to population aging and the need to adopt a healthy lifestyle.1 Lack of adherence to treatment is a major public health concern, with half of patients failing to comply with medical prescriptions.4 Antihypertensive and antidiabetic drugs are recommended only when non-medical interventions, such as dietary management, regular physical activity, and other practices associated with a healthy lifestyle have failed.5

Measures adopted to tackle NCDs have defined policies and actions worldwide.6 Studies investigating adherence to treatment have revealed pathways for the development of innovative strategies and behavioral interventions, aimed to support proper monitoring of prescribed therapies, with improved quality of life for patients.4

Interventions consist of health promotion actions leading to individual or collective behavior changes, according to the social context in which each individual is inserted, with a view to improving adherence to NCD therapy.7 A wide array of interventions can assist healthcare managers and services in NCD control, ranging from traditional methods, such as home visits and individual or group counselling, to technology-based approaches employed to send reminders or deliver content associated with health promotion.8

OBJECTIVE

To describe the state-of-the-art of scientific publications related to the development of interventions aimed to improve adherence to antihypertensive and antidiabetic therapy.

METHODS

Scienciometric study based on data collected between February and March 2018 via search of PubMed® (https://www.ncbi.nlm.nih.gov/pubmed/) and Scientific Electronic Library Online (SciELO; https://www.scielo.org/) databases.

PubMed® database search was conducted using the following search terms: “interventions to improve adherence to diabetes therapy”, “interventions to improve adherence to hypertension therapy” and “interventions to improve adherence to therapy for hypertension and diabetes”. SciELO database was searched using the following search terms: “ intervenções para melhorar a adesão à terapia do diabetes ”, “ intervenções para melhorar a adesão à terapia de hipertensão ” and “ intervenções para melhorar a adesão à terapia da hipertensão e diabetes ”.

Literature review and systematic literature review articles were excluded, and only original articles were selected for increased precision. Titles and abstracts were analyzed, and the articles classified under seven headings according to intervention type, as follows: face-to-face intervention, telephone-based intervention, digital intervention, indirect intervention, health education intervention, postal intervention or financial incentive intervention.

Data were entered into spreadsheets (Excel 2016) and tabulated according to year of publication, type of disease or target-audience, type of intervention, number of publications per continent and number of interventions per study.

RESULTS

Database search using selected terms yielded 600 publications in PubMed® and none in SciELO, between 2000 and 2018. Of these, 95 articles were selected following title and abstract analysis ( Table 1 - Appendix 1). Articles failing to meet inclusion criteria (505) were excluded.

Table 1 Articles included in the study 

Authors Year Títle Journal
Monroe AK, Pena JS, Moore RD, Riekert KA, Eakin MN, Kripalani S, Chander G 2018 Randomized controlled trial of a pictorial aid intervention for medication adherence among HIV-positive patients with comorbid diabetes or hypertension AIDS Care. 2018;30(2):199-206
do Valle Nascimento TM, Resnicow K, Nery M, Brentani A, Kaselitz E, Agrawal P, Mand S, Heisler M 2017 A pilot study of a Community Health Agent-led type 2 diabetes self-management program using Motivational Interviewing-based approaches in a public primary care center in São Paulo, Brazil BMC Health Serv Res. 2017;17(1):32
Wong CA, Miller VA, Murphy K, Small D, Ford CA, Willi SM, Feingold J, Morris A, Ha YP, Zhu J, Wang W, Patel MS 2017 Effect of Financial Incentives on Glucose Monitoring Adherence and Glycemic Control Among Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial JAMA Pediatr. 2017;171(12):1176-83
Frias J, Virdi N, Raja P, Kim Y, Savage G, Osterberg L 2017 Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial J Med Internet Res. 2017;19(7):e246
Davis SA, Carpenter D, Cummings DM, Lee C, Blalock SJ, Scott JE, Rodebaugh L, Ferreri SP, Sleath B 2017 Patient adoption of an internet based diabetes medication tool to improve adherence: a pilot study Patient Educ Couns. 2017;100(1):174-8
Floyd BD, Block JM, Buckingham BB, Ly T, Foster N, Wright R, Mueller CL, Hood KK, Shah AC 2017 Stabilization of glycemic control and improved quality of life using a shared medical appointment model in adolescents with type 1 diabetes in suboptimal control Pediatr Diabetes. 2017;18(3):204-12
Lewey J, Wei W, Lauffenburger JC, Makanji S, Chant A, DiGeronimo J, Nanchanatt G, Jan S, Choudhry NK 2017 Targeted Adherence Intervention to Reach Glycemic Control with Insulin Therapy for patients with Diabetes (TARGIT-Diabetes): rationale and design of a pragmatic randomised clinical trial BMJ Open. 2017;7(10):e016551
Di Bartolo P, Nicolucci A, Cherubini V, Iafusco D, Scardapane M, Rossi MC 2017 Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial Acta Diabetol. 2017;54(4):393-402
Albini F, Xiaoqiu Liu, Torlasco C, Soranna D, Faini A, Ciminaghi R, Celsi A, Benedetti M, Zambon A, di Rienzo M, Parati G 2016 An ICT and mobile health integrated approach to optimize patients’ education on hypertension and its management by physicians: The Patients Optimal Strategy of Treatment(POST) pilot study Conf Proc IEEE Eng Med Biol Soc. 2016;2016:517-20
Nelson LA, Mulvaney SA, Gebretsadik T, Ho YX, Johnson KB, Osborn CY 2016 Disparities in the use of a mHealth medication adherence promotion intervention for low-income adults with type 2 diabetes J Am Med Inform Assoc. 2016;23(1):12-8
Vissenberg C, Stronks K, Nijpels G, Uitewaal PJ, Middelkoop BJ, Kohinor MJ, Hartman MA, Nierkens V 2016 Impact of a social network-based intervention promoting diabetes self-management in socioeconomically deprived patients: a qualitative evaluation of the intervention strategies BMJ Open. 2016;6(4):e010254
Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Khan NF, Lee M, Vachon A, Iliadis TL, Hollands W, Doheny S, Elman S, Kraft JM, Naseem S, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD 2016 Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial Am Heart J. 2016;180:90-7
Piette JD, Marinec N, Janda K, Morgan E, Schantz K, Yujra AC, Pinto B, Soto JM, Janevic M, Aikens JE 2016 Structured Caregiver Feedback Enhances Engagement and Impact of Mobile Health Support: A Randomized Trial in a Lower-Middle-Income Country Telemed J E Health. 2016;22(4):261-8
Lynch CP, Williams JS, J Ruggiero K, G Knapp R, Egede LE 2016 Tablet-Aided BehavioraL intervention EffecT on Self-management skills (TABLETS) for Diabetes Trials. 2016;17:157
Kravetz JD, Walsh RF 2016 Team-Based Hypertension Management to Improve Blood Pressure Control J Prim Care Community Health. 2016;7(4):272-5
Mayberry LS, Berg CA, Harper KJ, Osborn CY 2016 The Design, Usability, and Feasibility of a Family-Focused Diabetes Self-Care Support mHealth Intervention for Diverse, Low-Income Adults with Type 2 Diabetes J Diabetes Res. 2016;2016:7586385
Lin TY, Chen CY, Huang YT, Ting MK, Huang JC, Hsu KH 2016 The effectiveness of a pay for performance program on diabetes care in Taiwan: a nationwide population-based longitudinal study Health Policy. 2016;120(11):1313-21
Reese PP, Kessler JB, Doshi JA, Friedman J, Mussell AS, Carney C, Zhu J, Wang W, Troxel A, Young P, Lawnicki V, Rajpathak S, Volpp K 2016 Two Randomized Controlled Pilot Trials of Social Forces to Improve Statin Adherence among Patients with Diabetes J Gen Intern Med. 2016;31(4):402-10
Duke DC, Wagner DV, Ulrich J, Freeman KA, Harris MA 2016 Videoconferencing for Teens With Diabetes: Family Matters J Diabetes Sci Technol. 2016;10(4):816-23
Schoenthaler A, De La Calle F, Barrios-Barrios M, Garcia A, Pitaro M, Lum A, Rosal M 2015 A practice-based randomized controlled trial to improve medication adherence among Latinos with hypertension: study protocol for a randomized controlled trial Trials. 2015;16:290
Volpp KG, Troxel AB, Long JA, Ibrahim SA, Appleby D, Smith JO, Jaskowiak J, Helweg-Larsen M, Doshi JA, Kimmel SE 2015 A randomized controlled trial of co-payment elimination: the CHORD trial. [ClinicalTrials.gov NCT00133068]. Am J Manag Care. 2015;21(8):e455-64
Volpp KG, Troxel AB, Long JA, Ibrahim SA, Appleby D, Smith JO, Jaskowiak J, Helweg-Larsen M, Doshi JA, Kimmel SE 2015 A randomized controlled trial of negative co-payments: the CHORD trial Am J Manag Care. 2015;21(8):e465-73
Fischer MA, Jones JB, Wright E, Van Loan RP, Xie J, Gallagher L, Wurst AM, Shrank WH 2015 A randomized telephone intervention trial to reduce primary medication nonadherence J Manag Care Spec Pharm. 2015;21(2):124-31
Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Maciosek MV, Nyboer RA, O’Connor PJ, Pawloski PA, Sperl-Hillen JM, Trower NK, Tucker AD, Green BB 2015 A Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why Did it Work? J Gen Intern Med. 2015;30(11):1665-72
Weiss DM, Casten RJ, Leiby BE, Hark LA, Murchison AP, Johnson D, Stratford S, Henderer J, Rovner BW, Haller JA 2015 Effect of Behavioral Intervention on Dilated Fundus Examination Rates in Older African American Individuals With Diabetes Mellitus: a Randomized Clinical Trial JAMA Ophthalmol. 2015;133(9):1005-12
Xin C, Xia Z, Jiang C, Lin M, Li G 2015 Effect of pharmaceutical care on medication adherence of patients newly prescribed insulin therapy: a randomized controlled study Patient Prefer Adherence. 2015;9:797-802
Fortuna RJ, Nagel AK, Rose E, McCann R, Teeters JC, Quigley DD, Bisognano JD, Legette-Sobers S, Liu C, Rocco TA 2015 Effectiveness of a multidisciplinary intervention to improve hypertension control in an urban underserved practice J Am Soc Hypertens. 2015;9(12):966-74
Friedberg JP, Rodriguez MA, Watsula ME, Lin I, Wylie-Rosett J, Allegrante JP, Lipsitz SR, Natarajan S 2015 Effectiveness of a tailored behavioral intervention to improve hypertension control: primary outcomes of a randomized controlled trial Hypertension. 2015;65(2):440-6
Wayne N, Perez DF, Kaplan DM, Ritvo P 2015 Health Coaching Reduces HbA1c in Type 2 Diabetic Patients From a Lower-Socioeconomic Status Community: A Randomized Controlled Trial J Med Internet Res. 2015;17(10):e224
Leon N, Surender R, Bobrow K, Muller J, Farmer A 2015 Improving treatment adherence for blood pressure lowering via mobile phone SMS-messages in South Africa: a qualitative evaluation of the SMS-text Adherence SuppoRt (StAR) trial BMC Fam Pract. 2015;16:80
Johnson RM, Johnson T, Zimmerman SD, Marsh GM, Garcia-Dominic O 2015 Outcomes of a Seven Practice Pilot in a Pay-For-Performance (P4P)-Based Program in Pennsylvania J Racial Ethn Health Disparities. 2015;2(1):139-48
Shane-McWhorter L, McAdam-Marx C, Lenert L, Petersen M, Woolsey S, Coursey JM, Whittaker TC, Hyer C, LaMarche D, Carroll P, Chuy L 2015 Pharmacist-provided diabetes management and education via a telemonitoring program J Am Pharm Assoc (2003). 2015;55(5):516-26
Kjeldsen LJ, Bjerrum L, Dam P, Larsen BO, Rossing C, Søndergaard B, Herborg H 2015 Safe and effective use of medicines for patients with type 2 diabetes – A randomized controlled trial of two interventions delivered by local pharmacies Res Social Adm Pharm. 2015;11(1):47-62
Chamany S, Walker EA, Schechter CB, Gonzalez JS, Davis NJ, Ortega FM, Carrasco J, Basch CE, Silver LD 2015 Telephone Intervention to Improve Diabetes Control: A Randomized Trial in the New York City A1c Registry Am J Prev Med. 2015;49(6):832-41
Cassimatis M, Kavanagh DJ, Hills AP, Smith AC, Scuffham PA, Gericke C, Parham S 2015 The OnTrack Diabetes Web-Based Program for Type 2 Diabetes and Dysphoria Self-Management: a Randomized Controlled Trial Protocol JMIR Res Protoc. 2015;4(3):e97
Baynouna LM, Neglekerke NJ, Ali HE, ZeinAlDeen SM, Al Ameri TA 2014 Audit of healthy lifestyle behaviors among patients with diabetes and hypertension attending ambulatory health care services in the United Arab Emirates Glob Health Promot. 2014;21(4):44-51
Jaser SS, Patel N, Linsky R, Whittemore R 2014 Development of a positive psychology intervention to improve adherence in adolescents with type 1 diabetes J Pediatr Health Care. 2014;28(6):478-85
Bobrow K, Brennan T, Springer D, Levitt NS, Rayner B, Namane M, Yu LM, Tarassenko L, Farmer A 2014 Efficacy of a text messaging (SMS) based intervention for adults with hypertension: protocol for the StAR (SMS Text-message Adherence suppoRt trial) randomised controlled trial BMC Public Health. 2014;14:28
Leslie RS, Tirado B, Patel BV, Rein PJ 2014 Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures J Manag Care Spec Pharm. 2014;20(12):1193-203
Zullig LL, Melnyk SD, Stechuchak KM, McCant F, Danus S, Oddone E, Bastian L, Olsen M, Edelman D, Rakley S, Morey M, Bosworth HB 2014 The Cardiovascular Intervention Improvement Telemedicine Study (CITIES): rationale for a tailored behavioral and educational pharmacist-administered intervention for achieving cardiovascular disease risk reduction Telemed J E Health. 2014;20(2):135-43
Fall E, Roche B, Izaute M, Batisse M, Tauveron I, Chakroun N. 2013 A brief psychological intervention to improve adherence in type 2 diabetes Diabetes Metab. 2013;39(5):432-8
Insel KC, Einstein GO, Morrow DG, Hepworth JT 2013 A multifaceted prospective memory intervention to improve medication adherence: design of a randomized control trial Contemp Clin Trials. 2013;34(1):45-52
Islam NS, Wyatt LC, Patel SD, Shapiro E, Tandon SD, Mukherji BR, Tanner M, Rey MJ, Trinh-Shevrin C 2013 Evaluation of a community health worker pilot intervention to improve diabetes management in Bangladeshi immigrants with type 2 diabetes in New York City Diabetes Educ. 2013;39(4):478-93
Adhien P, van Dijk L, de Vegter M, Westein M, Nijpels G, Hugtenburg JG 2013 Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy Int J Clin Pharm. 2013;35(6):1113-9
Moskowitz D, Thom DH, Hessler D, Ghorob A, Bodenheimer T 2013 Peer coaching to improve diabetes self-management: which patients benefit most? J Gen Intern Med. 2013;28(7):938-42
Mackenzie G, Ireland S, Moore S, Heinz I, Johnson R, Oczkowski W, Sahlas D 2013 Tailored interventions to improve hypertension management after stroke or TIA--phase II (TIMS II) Can J Neurosci Nurs. 2013;35(1):27-34
Matsumoto PM, Barreto AR, Sakata KN, Siqueira YM, Zoboli EL, Fracolli LA 2012 [Health education in the care to clients of the blood glucose self-monitoring program Rev Esc Enferm USP. 2012;46(3):761-5
Migneault JP, Dedier JJ, Wright JA, Heeren T, Campbell MK, Morisky DE, Rudd P, Friedman RH 2012 A culturally adapted telecommunication system to improve physical activity, diet quality, and medication adherence among hypertensive African-Americans: a randomized controlled trial Ann Behav Med. 2012;43(1):62-73
Brennan TA, Dollear TJ, Hu M, Matlin OS, Shrank WH, Choudhry NK, Grambley W 2012 An integrated pharmacy-based program improved medication prescription and adherence rates in diabetes patients Health Aff (Millwood). 2012;31(1):120-9
Gerber BS, Rapacki L, Castillo A, Tilton J, Touchette DR, Mihailescu D, Berbaum ML, Sharp LK 2012 Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes BMC Public Health. 2012;12:891
American Pharmacists Association 2012 DOTx. MED: Pharmacist-delivered interventions to improve care for patients with diabetes J Am Pharm Assoc (2003). 2012;52(1):25-33
Ellis DA, Naar-King S, Chen X, Moltz K, Cunningham PB, Idalski-Carcone A 2012 Multisystemic therapy compared to telephone support for youth with poorly controlled diabetes: findings from a randomized controlled trial Ann Behav Med. 2012;44(2:207-15
Zolfaghari M, Mousavifar SA, Pedram S, Haghani H 2012 The impact of nurse short message services and telephone follow-ups on diabetic adherence: which one is more effective? J Clin Nurs. 2012;21(13-14):1922-31. Retraction in: J Clin Nurs. 2016;25(11-12):1781
Cooper LA, Roter DL, Carson KA, Bone LR, Larson SM, Miller ER 3rd, Barr MS, Levine DM 2011 A randomized trial to improve patient-centered care and hypertension control in underserved primary care patients J Gen Intern Med. 2011;26(11):1297-304
Oberg EB, Bradley RD, Allen J, McCrory MA 2011 CAM: naturopathic dietary interventions for patients with type 2 diabetes Complement Ther Clin Pract. 2011;17(3): 157-61
Jing S, Naliboff A, Kaufman MB, Choy M 2011 Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members J Manag Care Pharm. 2011;17(5):355-66
Mitchell B, Armour C, Lee M, Song YJ, Stewart K, Peterson G, Hughes J, Smith L, Krass I 2011 Diabetes Medication Assistance Service: the pharmacist’s role in supporting patient self-management of type 2 diabetes (T2DM) in Australia Patient Educ Couns. 2011;83(3):288-94
Labhardt ND, Balo JR, Ndam M, Manga E, Stoll B 2011 Improved retention rates with low-cost interventions in hypertension and diabetes management in a rural African environment of nurse-led care: a cluster-randomised trial Trop Med Int Health. 2011;16(10):1276-84
Martin MY, Kim YI, Kratt P, Litaker MS, Kohler CL, Schoenberger YM, Clarke SJ, Prayor-Patterson H, Tseng TS, Pisu M, Williams OD 2011 Medication adherence among rural, low-income hypertensive adults: a randomized trial of a multimedia community-based intervention Am J Health Promot. 2011;25(6):372-8
Morgado M, Rolo S, Castelo-Branco M 2011 Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial Int J Clin Pharm. 2011;33(1):132-40
Griffin SJ, Simmons RK, Williams KM, Prevost AT, Hardeman W, Grant J, Whittle F, Boase S, Hobbis I, Brage S, Westgate K, Fanshawe T, Sutton S, Wareham NJ, Kinmonth AL; ADDITION-Plus study team. 2011 Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care BMC Public Health. 2011;11:211
Shah BR, Adams M, Peterson ED, Powers B, Oddone EZ, Royal K, McCant F, Grambow SC, Lindquist J, Bosworth HB 2011 Secondary prevention risk interventions via telemedicine and tailored patient education (SPRITE): a randomized trial to improve postmyocardial infarction management Circ Cardiovasc Qual Outcomes. 2011;4(2):235-42
Carter BL, Doucette WR, Franciscus CL, Ardery G, Kluesner KM, Chrischilles EA 2010 Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention Pharmacotherapy. 2010;30(3):228-35
Criswell TJ, Weber CA, Xu Y, Carter BL 2010 Effect of self-efficacy and social support on adherence to antihypertensive drugs Pharmacotherapy. 2010;30(5):432-41
Lau R, Stewart K, McNamara KP, Jackson SL, Hughes JD, Peterson GM, Bortoletto DA, McDowell J, Bailey MJ, Hsueh A, George J 2010 Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial BMC Health Serv Res. 2010;10:34
Robinson JD, Segal R, Lopez LM, Doty RE 2010 Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice Ann Pharmacother. 2010;44(1):88-96
Mishali M, Sominsky L, Heymann AD. 2010 Reducing resistance to diabetes treatment using short narrative interventions Fam Pract. 2010;27(2):192-7
Lehmkuhl HD, Storch EA, Cammarata C, Meyer K, Rahman O, Silverstein J, Malasanos T, Geffken G 2010 Telehealth behavior therapy for the management of type 1 diabetes in adolescents J Diabetes Sci Technol. 2010;4(1):199-208
Williams AF, Manias E, Walker RG 2010 The devil is in the detail - a multifactorial intervention to reduce blood pressure in co-existing diabetes and chronic kidney disease: a single blind, randomized controlled trial BMC Fam Pract. 2010;11:3
Bonds DE, Hogan PE, Bertoni AG, Chen H, Clinch CR, Hiott AE, Rosenberger EL, Goff DC. 2009 A multifaceted intervention to improve blood pressure control: the Guideline Adherence for Heart Health (GLAD) study Am Heart J. 2009;157(2):278-84
Feldman PH, McDonald MV, Mongoven JM, Peng TR, Gerber LM, Pezzin LE 2009 Home-based blood pressure interventions for blacks Circ Cardiovasc Qual Outcomes. 2009;2(3):241-8
Dolor RJ, Yancy WS Jr, Owen WF, Matchar DB, Samsa GP, Pollak KI, Lin PH, Ard JD, Prempeh M, McGuire HL, Batch BC, Fan W, Svetkey LP 2009 Hypertension Improvement Project (HIP): study protocol and implementation challenges Trials. 2009;10:13
Christie D, Strange V, Allen E, Oliver S, Wong IC, Smith F, Cairns J, Thompson R, Hindmarsh P, O’Neill S, Bull C, Viner R, Elbourne D 2009 Maximising engagement, motivation and long term change in a Structured Intensive Education Programme in Diabetes for children, young people and their families: Child and Adolescent Structured Competencies Approach to Diabetes Education (CASCADE) BMC Pediatr. 2009;9:57
Bosworth HB, Olsen MK, Dudley T, Orr M, Goldstein MK, Datta SK, McCant F, Gentry P, Simel DL, Oddone EZ 2009 Patient education and provider decision support to control blood pressure in primary care: a cluster randomized trial Am Heart J. 2009;157(3):450-6
Svarstad BL, Kotchen JM, Shireman TI, Crawford SY, Palmer PA, Vivian EM, Brown RL 2009 The Team Education and Adherence Monitoring (TEAM) trial: pharmacy interventions to improve hypertension control in blacks Circ Cardiovasc Qual Outcomes. 2009;2(3):264-71
Green BB, Ralston JD, Fishman PA, Catz SL, Cook A, Carlson J, Tyll L, Carrell D, Thompson RS 2008 Electronic communications and home blood pressure monitoring (e-BP) study: design, delivery, and evaluation framework Contemp Clin Trials. 2008;29(3):376-95
Farmer AJ, Prevost AT, Hardeman W, Craven A, Sutton S, Griffin SJ, Kinmonth AL; Support and Advice for Medication Trial Group 2008 Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication BMC Fam Pract. 2008;9:20
Bosworth HB, Olsen MK, McCant F, Harrelson M, Gentry P, Rose C, Goldstein MK, Hoffman BB, Powers B, Oddone EZ 2007 Hypertension Intervention Nurse Telemedicine Study (HINTS): testing a multifactorial tailored behavioral/educational and a medication management intervention for blood pressure control Am Heart J. 2007;153(6):918-24
Lin D, Hale S, Kirby E 2007 Improving diabetes management: structured clinic program for Canadian primary care Can Fam Physician. 2007;53(1):73-7
Ellis DA, Naar-King S, Templin T, Frey MA, Cunningham PB 2007 Improving health outcomes among youth with poorly controlled type I diabetes: the role of treatment fidelity in a randomized clinical trial of multisystemic therapy J Fam Psychol. 2007;21(3):363-71
Lin PH, Appel LJ, Funk K, Craddick S, Chen C, Elmer P, McBurnie MA, Champagne C 2007 The PREMIER intervention helps participants follow the Dietary Approaches to Stop Hypertension dietary pattern and the current Dietary Reference Intakes recommendations J Am Diet Assoc. 2007;107(9):1541-51
Bosworth HB, Olsen MK, Dudley T, Orr M, Neary A, Harrelson M, Adams M, Svetkey LP, Dolor RJ, Oddone EZ 2007 The Take Control of Your Blood pressure (TCYB) study: study design and methodology Contemp Clin Trials. 2007;28(1):33-47
Johnson SS, Driskell MM, Johnson JL, Prochaska JM, Zwick W, Prochaska JO 2006 Efficacy of a transtheoretical model-based expert system for antihypertensive adherence. Dis Manag. 2006t;9(5):291-301
Roumie CL, Elasy TA, Greevy R, Griffin MR, Liu X, Stone WJ, Wallston KA, Dittus RS, Alvarez V, Cobb J, Speroff T 2006 Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial Ann Intern Med. 2006;145(3):165-75
Jenkins RG, Ornstein SM, Nietert PJ, Klockars SJ, Thiedke C 2006 Quality improvement for prevention of cardiovascular disease and stroke in an academicfamily medicine center: do racial differences in outcome exist? Ethn Dis. 2006;16(1):132-7
Odegard PS, Goo A, Hummel J, Williams KL, Gray SL 2005 Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention Ann Pharmacother. 2005;39(3):433-40
Szirmai LA, Arnold C, Farsang C 2005 Improving control of hypertension by an integrated approach -- results of the ‘Manage it well!’ programme J Hypertens. 2005;23(1):203-11
Bosworth HB, Olsen MK, Goldstein MK, Orr M, Dudley T, McCant F, Gentry P, Oddone EZ 2005 The veterans’ study to improve the control of hypertension (V-STITCH): design and methodology Contemp Clin Trials. 2005;26(2):155-68
Bailie RS, Si D, Robinson GW, Togni SJ, D’Abbs PH 2004 A multifaceted health-service intervention in remote Aboriginal communities: 3-year follow-up of the impact on diabetes care Med J Aust. 2004;181(4):195-200
New JP, Mason JM, Freemantle N, Teasdale S, Wong L, Bruce NJ, Burns JA, Gibson JM 2004 Educational outreach in diabetes to encourage practice nurses to use primary care hypertension and hyperlipidaemia guidelines (EDEN): a randomized controlled trial Diabet Med. 2004;21(6):599-603
Clark M, Hampson SE, Avery L, Simpson R 2004 Effects of a tailored lifestyle self-management intervention in patients with type 2 diabetes Br J Health Psychol. 2004;9(Pt 3):365-79
Franklin V, Waller A, Pagliari C, Greene S 2003 “Sweet Talk”: text messaging support for intensive insulin therapy for young people with diabetes Diabetes Technol Ther. 2003;5(6):991-6
Côté I, Grégoire JP, Moisan J, Chabot I, Lacroix G 2003 A pharmacy-based health promotion programme in hypertension: cost-benefit analysis Pharmacoeconomics. 2003;21(6):415-28
Johnson BF, Hamilton G, Fink J, Lucey G, Bennet N, Lew R 2000 A design for testing interventions to improve adherence within a hypertension clinical trial Control Clin Trials. 2000;21(1):62-72
Nyman MA, Murphy ME, Schryver PG, Naessens JM, Smith SA 2000 Improving performance in diabetes care: a multicomponent intervention Eff Clin Pract. 2000;3(5):205-12

Data analysis revealed scientific production growth as of 2009, with a higher volume of publications describing interventions aimed to improve adherence to antihypertensive and antidiabetic therapy, between 2015 and 2017 ( Figure 1 ).

Figure 1 Number of articles listed on PubMed® according to period of publication 

Studies focusing on interventions aimed at diabetes patients were more abundant (46.3%; n=44), followed by articles describing interventions aimed at hypertension (37.9%; n=36). Only 15.8% (n=15) of articles described interventions aimed at both diseases ( Figure 2 ).

Figure 2 Number of scientific articles according to type of disease 

Most articles (63.2%; n=60) described a single intervention, whereas remaining articles included two (30.5%; n=29) or more (6.3%; n=6) concurrent interventions. Classification according to type of intervention was as follows: face-to-face, 46.3% (n=44); telephone-based, 31.6% (n=30); digital, 26.3% (n=25); indirect, 16.9% (n=16); health education, 12.7% (n=12); postal, 6.3% (n=6); and financial incentive, 5.2% (n=5) ( Figure 3 ).

Figure 3 Thematic axis profile of scientific articles describing types of interventions aimed to improve adherence to antihypertensive and antidiabetic therapy 

Interventions were defined as follows: (1) face-to-face - individual appointments in clinics and home visits by health professionals; (2) telephone-based - whenever conducted over the telephone; (3) digital - SMS text messages, Apps or software ( WhatsApp, etc.); (4) indirect - public policies, audits, guidelines and professional training; (5) health education - talks and orientations given to patients; (6) postal - letters sent by regular mail; and (7) financial incentive - payments made or discounts given for financial compensation of patients.

Article distribution according to continent of origin revealed larger numbers of studies conducted in North America (68.4%; n=65) or Europe (14.8%; n=14), with only a small proportion (3.1%; n=3) from South America.

DISCUSSION

In this study, the findings derived from the analysis of scientific publications emphasize the importance of the topic selected in the realm of public policies aimed at health promotion, as shown by adoption of control measures by several counties in the face of increased prevalence of hypertension and diabetes.9 This process has led to the application of different interventions resulting in clinical improvement of patients and lower health care costs.10

The World Health Organization (WHO), driven by some countries, such as the United States, Canada, Australia and the United Kingdom, expected to reduce mortality rates associated with chronic diseases by 2% per year, up to 2015.11 With these estimates in mind, joint efforts by the WHO, governments, world organizations and the private sector approved the Global Action Plan for the Prevention and Control of NCDs 2013-2020. The WHO has also set voluntary targets for 2025, among which the reduction of premature mortality due to these diseases by 25%.1

The higher number of scientific publications on interventions in the last decade may reflect population aging, given physiological changes tend to increase with age, leading to higher prevalence of NCDs.12 Improved basic health care, growing urbanization, global commercialization of health harming products, and adoption of unhealthy life styles may have boosted scientific production during this period.2

Hypertension is a silent disease affecting individuals of all socioeconomic levels, with higher mortality and global prevalence rates compared to other NCDs;5 still, studies investigating interventions aimed at diabetic patients are even more abundant. This may be explained by the diversity of acute and chronic complications associated with diabetes mellitus and the two- to three-fold increase in health costs over the years as compared to costs associated with non-diabetic patients.2 In 2017, estimated global costs of diabetes amounted to US$ 850 billion, with significant social and economic impacts on healthcare systems.2

As regards different types of interventions promoting adherence to medical and non-medical antihypertensive and antidiabetic therapy, face-to-face interventions consisting of individual appointments and home visits were more commonly described in scientific literature.13 Individual appointments are widely used in outpatient services, clinics, community pharmacies, multidisciplinary health teams14 and other health centers, since they represent traditional methods involving joint analysis of barriers to adherence to therapy, and solutions for improved health outcomes, by physicians, pharmacists, nurses, psychologists, dietitians, physical educators and patients.15

Telephone-based interventions also proved to be efficient, since these encourage patients with several comorbidities to adopt best care practices via telephone call monitoring.16 This type of traditional intervention is widely used by pharmacists in community pharmacies and clinics; as drug managers, pharmacists provide guidance to patients regarding health behaviors, thereby contributing to improved adherence to medical and non-medical antihypertensive and antidiabetic therapy.17 Telephone-based services constitute more accessible alternatives, with reduced medical appointment load, lower transportation costs for low-income patients and the added benefit of proposing the insertion of personalized information.18

Digital interventions consisting of SMS text messages, Web, apps and WhatsApp have been attracting increasing attention in studies investigating adherence to treatment over the last few years. Such technology tools facilitate access to health information aimed to improve patients’ quality of life.19 One study has shown that combined technologies may encourage health behavior changes and increase adherence to antihypertensive and antidiabetic therapy.20

Digital interventions were shown to be particularly effective in underdeveloped and developing countries, for ensuring access to health benefits from remote areas worldwide via widely available technology.21 Mobile health tools, or m-Health, are a major trend in NCD control, given their low cost and ability to provide remote health care.22

Other interventions designed to improve health behavior in hypertensive and diabetic patients described in literature include indirect interventions, comprising public policies, health guidelines, audits and professional training.23

Health education interventions are often implemented by nurses and other health professionals by means of talks and group guidance sessions, particularly in communities where technological resources are limited or lacking.24 Studies describing postal interventions, consisting of letters containing health recommendations were scarce.25 Finally, financial incentive interventions applied by some health services, particularly the private sector, to encourage patient adherence out of financial compensation, were seldom described.26

As regards study origin, most scientific research related to interventions tailored to hypertensive and diabetic individuals were conducted in North America, followed by European countries. In the United States, for example, one in every three individuals, or 75.2 million American citizens suffer from hypertension, and almost half this population (35 million people) has blood pressure levels above recommendations.27 From 2011 to 2014, the US hypertension prevalence averaged 34% (34.5% and 33.4%, in men and women respectively); prevalence in the elderly population was 67.2%, with approximately 410,624 deaths due to primary or secondary causes, and a total cost of US$ 51.2 billion between 2012 and 2013.28

Diabetes affected approximately 30.3 million Americans in 2015, with 9.4% prevalence. Diabetes was the seventh cause of death in the country, with more than 252,806 deaths resulting directly or indirectly from the disease, annually.29 In 2017, total diabetes costs amounted to US$ 327 billion, with individuals aged 65 years or older accounting for most of the financial burden, and driving rising healthcare budget requirements.2 The 2010 estimated prevalence of diagnosed and undiagnosed diabetes in the adult population of 14% is expected increase to 21% up to 2050.30

Obesity is a major factor in the growing prevalence of other NCDs and has been associated with rising numbers of premature deaths due to hypertension and diabetes, particularly in countries such as the United States, where consumption of industrialized foods is high. Poor dietary habits resulted in 17% prevalence of obesity among children, and approximately one-third of the adult population (36.5%) affected between 2011 and 2014, particularly middle-aged individuals (40 to 59 years).29

The number of studies on interventions conducted in European countries has also increased. Population aging in these countries has led to a constant rise in NCD prevalence and sparked interest in strategies aimed at reducing the burden of health care costs.31

In South America, a continent comprising developing countries, studies investigating interventions aimed to increase adherence to antihypertensive and antidiabetic therapy are quite recent, and in lesser numbers compared to North America. In Brazil, improved health status and increased life expectancy translated into 18% growth of the aging population over the last 5 years, from 25.4 million in 2012, to 30 million in 2017. These factors contributed to growing estimated NCD prevalence over the course of one decade, with 14.2% increase in hypertension prevalence (from 22.5% to 25.7%, between 2006 and 2016) and 61.8% increase in diabetes prevalence (from 5.5% to 8.9%, between 2006 and 2016).32

High NCD prevalence in 2015 led to 424,058 deaths due to cardiovascular diseases, and 62,466 deaths due to diabetes,33 with total costs amounting to US$ 4.18 and US$ 22 billion, respectively.6 , 9 Over the last few years, lifestyle changes among Brazilian citizens have had significant impacts on obesity-related comorbidity rates, another important risk-factor for hypertension and diabetes.5 Obesity rates increased 60% in Brazil in 10 years, from 11.8% in 2006 to 18.9% in 2016, with higher prevalence (22.9%) among individuals aged 55 to 64 years.32

Brazil has adopted important measures to tackle NCDs over the last few years, such as establishing the Sistema de Vigilância de Doenças Crônicas Não Transmissíveis (VIGITEL) [Surveillance System for Non-communicable Chronic Diseases], for permanent monitoring of chronic diseases and assessment of the best intervention strategies.32 Creation of Plano de Ações para o Enfrentamento de DCNT 2011-2022 [Action Plan to Tackle NCDs 2011-2022] was another important measure encouraging the development of public policies aimed at health promotion, with significant contributions to the achievement of goals, such as 2% annual reduction in premature deaths due to NCDs until 2022,6 so as to ensure sustainable health development for the 2030 Agenda.34

Studies based on a single type of intervention were more common. In many countries, healthcare provision to elderly patients with two or more comorbidities poses a greater challenge to managers and health professionals. Interventions aimed to increase adherence to treatment require guidelines focused on incentives for patients in this age group.35 In the United States, delivery of multiple interventions to the same patient failed to improve health outcomes due to disease-specific requirements and higher costs. Therefore, comprehensive tools focused on patient quality of life rather than disease alone must be sought after.35

CONCLUSION

This scientometric study revealed significant gaps. The number of studies conducted in Latin America, particularly in Brazil, was small, in contrast with the growing prevalence of hypertension and diabetes in the country and the Latin American continent overall. Financial incentive interventions were limited to some developed countries; still, despite limited evidence, this type of intervention may be a promising strategy for behavior change promotion. Studies investigating interventions designed to improve adherence to treatment by patients with comorbidities, such as hypertension and diabetes, were scarce.

Finally, traditional interventions such as face-to-face interviews or telephone calls were more commonly used to encourage adherence to antihypertensive and antidiabetic therapy, in spite of the current trend of digital technology application to leverage health behavior changes.

ACKNOWLEDGEMENTS

To Instituto Cesumar de Ciência, Tecnologia e Inovação - ICETI for the scholarship; and to Fundação Araucária - PR/SESA-PR/CNPq/MS/PPSUS for funding the research.

REFERENCES

1. World Health Organization (WHO). Global status report on noncommunicable diseases 2014 [Internet]. Genebra: WHO; 2014 [cited 2018 Oct 3]. Available from: http://www.who.int/nmh/publications/ncd-status-report-2014/en/Links ]

2. American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917-28. [ Links ]

3. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Secretaria de Atenção à Saúde. Política Nacional de Promoção da Saúde (PNPS): Revisão da Portaria MS/GM no687, de 30 de março de 2006 [Internet]. Brasília (DF): Ministério da Saúde; 2015. 36 p. [citado 2018 Out 3]. Disponível em: http://bvsms.saude.gov.br/bvs/publicacoes/pnps_revisao_portaria_687.pdfLinks ]

4. Souza AC, Borges JW, Moreira TM. Quality of life and treatment adherence in hypertensive patients: systematic review with meta-analysis. Rev Saude Publica. 2016;50:71. Review. [ Links ]

5. Oliveira GM, Mendes M, Malachias MV, Morais J, Moreira O, Coelho AS, et al. 2017 Guidelines for Arterial Hypertension Management in Primary Health Care in Portuguese Language Countries. Arq Bras Cardiol. 2017;109(5):389-96. [ Links ]

6. Malta DC, Oliveira TP, Santos MA, Andrade SS, Silva MM; Grupo Técnico de Monitoramento do Plano de DCNT. Progress with the Strategic Action Plan for Tackling Chronic Non-Communicable Diseases in Brazil, 2011-2015. Epidemiol Serv Saude. 2016;25(2):373-390. [ Links ]

7. Sheppard-Law S, Zablotska-Manos I, Kermeen M, Holdaway S, Lee A, George J, et al. Factors associated with non-adherence to HBV antiviral therapy. Antivir Ther. 2018;23(5):425-33. [ Links ]

8. Ryan R, Santesso N, Lowe D, Hill S, Grimshaw J, Prictor M, et al. Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev. 2014;(4):CD007768. Review. [ Links ]

9. Diretrizes da sociedade brasileira de diabetes 2017-2018 [Internet]. São Paulo: Clannad; 2017 [citado 2019 Nov 5]. Disponível em: https://www.diabetes.org.br/profissionais/images/2017/diretrizes/diretrizes-sbd-2017-2018.pdfLinks ]

10. Olney JJ, Braitstein P, Eaton JW, Sang E, Nyambura M, Kimaiyo S, et al. Evaluating strategies to improve HIV care outcomes in Kenya: a modelling study. Lancet HIV. 2016;3(12):e592-600. [ Links ]

11. World Health Organization (WHO). WHO methods and data sources for country-level causes of death 2000-2015 [Internet]. Genebra: WHO; 2017 [cited 2018 Oct 3]. Available from: http://www.who.int/healthinfo/global_burden_disease/GlobalCOD_method_2000_2015.pdf?ua=1Links ]

12. Miranda GM, Mendes AC, da Silva AL. Population aging in Brazil: current and future social challenges and consequences. Rev Bras Geriatr Gerontol. 2016;19(3):507-19. [ Links ]

13. Kravetz JD, Walsh RF. Team-Based Hypertension Management to Improve Blood Pressure Control. J Prim Care Community Health. 2016;7(4):272-5. [ Links ]

14. Pannick S, Davis R, Ashrafian H, Byrne BE, Beveridge I, Athanasiou T, et al. Effects of Interdisciplinary Team Care Interventions on General Medical Wards: A Systematic Review. JAMA Intern Med. 2015;175(8):1288-98. Review. [ Links ]

15. Floyd BD, Block JM, Buckingham BB, Ly T, Foster N, Wright R, et al. Stabilization of glycemic control and improved quality of life using a shared medical appointment model in adolescents with type 1 diabetes in suboptimal control. Pediatr Diabetes. 2017;18(3):204-12. [ Links ]

16. Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, et al. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan. J Manag Care Spec Pharm. 2016;22(1):63-73. [ Links ]

17. Shane-McWhorter L, McAdam-Marx C, Lenert L, Petersen M, Woolsey S, Coursey JM, et al. Pharmacist-provided diabetes management and education via a telemonitoring program. J Am Pharm Assoc (2003). 2015;55(5):516-26. [ Links ]

18. Friedberg JP, Rodriguez MA, Watsula ME, Lin I, Wylie-Rosett J, Allegrante JP, et al. Effectiveness of a tailored behavioral intervention to improve hypertension control: primary outcomes of a randomized controlled trial. Hypertension. 2015;65(2):440-6. [ Links ]

19. Ruiz Morilla MD, Sans M, Casasa A, Giménez N. Implementing technology in healthcare: insights from physicians. BMC Med Inform Decis Mak. 2017;17(1):92. [ Links ]

20. Frias J, Virdi N, Raja P, Kim Y, Savage G, Osterberg L. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial. J Med Internet Res. 2017;19(7):e246. [ Links ]

21. Howitt P, Darzi A, Yang GZ, Ashrafian H, Atun R, Barlow J, et al. Technologies for global health. Lancet. 2012;380(9840):507-35. Review. [ Links ]

22. Piette JD, List J, Rana GK, Townsend W, Striplin D, Heisler M. Mobile Health Devices as Tools for Worldwide Cardiovascular Risk Reduction and Disease Management. Circulation. 2015;132(21):2012-27. [ Links ]

23. do Valle Nascimento TM, Resnicow K, Nery M, Brentani A, Kaselitz E, Agrawal P, et al. A pilot study of a Community Health Agent-led type 2 diabetes self-management program using Motivational Interviewing-based approaches in a public primary care center in São Paulo, Brazil. BMC Health Serv Res. 2017;17(1):32. [ Links ]

24. Schoenthaler A, De La Calle F, Barrios-Barrios M, Garcia A, Pitaro M, Lum A, et al. A practice-based randomized controlled trial to improve medication adherence among Latinos with hypertension: study protocol for a randomized controlled trial. Trials. 2015;16(1):290. [ Links ]

25. Jing S, Naliboff A, Kaufman MB, Choy M. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members. J Manag Care Pharm. 2011;17(5):355-66. [ Links ]

26. Wong CA, Miller VA, Murphy K, Small D, Ford CA, Willi SM, et al. Effect of Financial Incentives on Glucose Monitoring Adherence and Glycemic Control Among Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA Pediatr. 2017;171(12):1176-83. [ Links ]

27. Merai R, Siegel C, Rakotz M, Basch P, Wright J, Wong B; DHSc, Thorpe P. CDC Grand Rounds: A Public Health Approach to Detect and Control Hypertension. MMWR Morb Mortal Wkly Rep. 2016;65(45):1261-4. [ Links ]

28. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135(10):e146-e603. Review. Erratum in: Circulation. 2017;135(10):e646. Circulation. 2017;136(10):e196. [ Links ]

29. Centers for Disease Control and Prevention. National Diabetes Statistics Report 2017: Estimates of Diabetes and Its Burden in the United States. Atlanta (GA): Centers for Disease Control and Prevention; 2017. [ Links ]

30. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29. [ Links ]

31. Kingston A, Robinson L, Booth H, Knapp M, Jagger C; MODEM project. Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model. Age Ageing. 2018;47(3):374-80. [ Links ]

32. Malta DC, Silva MM, Moura L, Morais OL. A implantação do Sistema de Vigilância de Doenças Crônicas Não Transmissíveis no Brasil, 2003 a 2015: alcances e desafios. Rev Bras Epidemiol. 2017;20(4):661-75. [ Links ]

33. Malta DC, França E, Abreu DM, Perillo RD, Salmen MC, Teixeira RA, et al. Mortality due to noncommunicable diseases in Brazil, 1990 to 2015, according to estimates from the Global Burden of Disease study. Sao Paulo Med J. 2017;135(3):213-21. [ Links ]

34. World Health Organization (WHO). World Health Statistics 2016: Monitoring health for the SDGs. Genebra: WHO; 2016. [ Links ]

35. Applegate WB. Across the Pond. J Am Geriatr Soc. 2017;65(5):901-2. [ Links ]

Received: August 8, 2018; Accepted: June 18, 2019

Corresponding author: Julio de Souza Sá Avenida Guedner, 1610 – Zona 08 Zip code: 8750-9000 – Maringá, PR, Brazil Phone: (55 44) 3021-6360 E-mail: julio_ssa@hotmail.com

Conflict of interest: none.

Creative Commons License  This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.